期刊文献+

天然多酚衍生物抗肿瘤侵袭与转移研究进展 被引量:2

Progress on natural polyphenols as anti-invasive and anti-metastasis agents
原文传递
导出
摘要 肿瘤侵袭与转移是恶性肿瘤的基本特征,是临床肿瘤患者死亡的最主要原因。肿瘤侵袭与转移过程涉及细胞的脱落、浸润、迁移运行、着床、新生血管生成等过程,作用机制非常复杂,因此,防止肿瘤转移一直是肿瘤治疗的难题。近年来研究发现,许多天然产物具有抗肿瘤侵袭和转移能力,该文对天然多酚类化合物的抗肿瘤侵袭和转移作用的研究进展进行综述。 The ability to invade and metastasize is a hallmark of malignant tumors,and metastasis poses the biggest problem to cancer treatment and is the main cause of death of cancer patients.Tumor invasion and metastasis are complex,multistep biochemical process,which involve cell detachment,invasion,migration,intravasation and circulation,implantation,angiogenesis and proliferation.Therefore,how to prevent tumor metastasis are the biggest challenge in cancer chemotherapy.In recent years,many natural products are found to have anti-invasion and anti-metastasis activities.In this paper,the natural polyphenolic compounds are classified according to their chemical structures including diarylheptanoids,stibenoids,flavonoids,phenylpropanoids,cannabinoids and naphthoquinones,and their anti-invasion and anti-metastasis activities and biological targets are introduced.
出处 《中国药物化学杂志》 CAS CSCD 2011年第1期60-69,共10页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金项目(30873134 81072517)
关键词 肿瘤 侵袭 转移 天然产物 多酚 tumor invasion metastasis natural product polyphenols
  • 相关文献

参考文献40

  • 1STEEG P S, THEODORESCU D. Metastasis:a therapeutic target for cancer [ J ]. Nat Clin Prac Oncol,2008,5(4) :206 -219.
  • 2HAYOTA C,DEBEIRB O, HAMB P V, et al. Characterization of the activities of actin-affecting drugs on tumor cell migration [J]. Toxicol Appl Pharmacol,2006,211 (11) :30 -40.
  • 3GERMANOV E, BERMAN J N, GUERNSEY D L. Current and future approaches for the therapeutic targeting of metastasis [ J]. Int J Mol Med, 2006, 18 (16) :1025 - 1036.
  • 4BRACKE M E, VANHOECKE B W A, DERYCKE L, et al. Plant polyphenolics as anti-invasive cancer agents [ J ]. Anticancer Agents Med Chem, 2008,8 (2) :171 - 185.
  • 5KUTTAN G, KUMAR K B, GURUVAYOORAP- PAN C, et al. Anti-tumor, anti-invasion, and anti-metastatic effect of curcumin [ J ]. Adv Exp Med Biol, 2007,595 : 173 - 184.
  • 6MENON L G, KUTTAN R, KUTTAN G. Anti-metastatic activity of curcumin and catechin [ J]. Cancer Lett,1999,141 ( 1 ) :159 - 165.
  • 7RAY S, CHATTOPADHYAY N, MITRA A, et al. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin [ J] . J Environ Pathol Toxicol Oncol,2003,22( 1 ) :49 - 58.
  • 8AGGARWAL B B, SHISHODIA S, TAKADA Y, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice [J ]. Clin Cancer Res, 2005, 11 ( 20 ) : 7490 - 7498.
  • 9YODKEEREE S, AMPASAVATE C, SUNG B, et al. Demethoxycurcumin suppresses migration and in- vasion of MDA-MB-231 human breast cancer cell line[ J]. Eur J Pharmacol,2010,627 (1/3) :8 - 15.
  • 10YODKEEREEA S, CHAlWANGYENA W, GAR- BISAB S, et al. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA[ J]. J Nutr Biochem ,2009,20(2) :87-95.

同被引文献30

  • 1AL-Hajj M, Wicha M S, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer ceils [J]. Proc Natl Acad Sci, 2003, 100(7): 3983.
  • 2Davis N M, Sokolosky M, Stadelman K, et al. Deregulation of the EGFR/PI3 K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention [J]. Oncotarget, 2014, 5(13): 4603.
  • 3Lu J, Steeg P S, Price J E, et al. Breast cancer metastasis: challenges and opportunities[J]. Cancer Res, 2009, 69(12): 4951.
  • 4Chiang A C, Massagu J. Molecular basis of metastasis[J]. N Engl J Med, 2008, 359(26): 2814.
  • 5Culhane A C, Quackenbush J. Confounding effects in "A six-gene signature predicting breast cancer lung metastasis" [J]. Cancer Res, 2009, 69(18): 7480.
  • 6Ming A J, Kang Y, Serganova I, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors [J]. J Clin Invest, 2005, 115(1): 44.
  • 7Jin M N, Ma S N, Zhai H Y, et al. A New megastigmane alkaloid from pachysandra terminalis with antitumor metastasis effect [J]. Chem Nat Compd, 2015, 51(2): 311.
  • 8Wu J, Zhang B, Wu M, et al. Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell ehemotaxis [J]. Invest New Drugs, 2010, 28(3): 268.
  • 9Zhai H Y, Zhao C, Zhang N, et al. Alkaloids from Pachysandra terminalis inhibit breast cancer invasion and have potential for development as antimetastasis therapeutic agents[J]. J Nat Prod, 2012, 75(7): 1305.
  • 10Wang H L, Qin N, Liu J, et al. Synthesis and antimetastatic effects of E-salignone amide derivatives[J]. Drug Dev Res, 2014, 75(2): 76.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部